{"id":"W2588570873","doi":"10.1016/j.ejca.2017.08.019","title":"Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"Universitätsklinikum Hamburg-Eppendorf; Centre Léon Bérard; Assistance publique-Hôpitaux de Paris; Baskent Üniversitesi; Gaziantep Üniversitesi; Ege Üniversitesi; Institut Bergonié; University of Sussex; F. Hoffmann-La Roche; Roche","keywords":"Trastuzumab; Medicine; Breast cancer; Adjuvant; Oncology; Internal medicine; Adjuvant therapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001913847,0.0002471016,0.001299681,0.0002045103,0.0001857262,0.00004037609,0.000452214,0.00003662748,0.0001743371],"category_scores_gemma":[0.0001690608,0.0001578927,0.0003493819,0.0002288852,0.0005749318,0.00009383882,0.0000837159,0.0003837993,2.322076e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001689554,"about_ca_system_score_gemma":0.0006276778,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001128948,"about_ca_topic_score_gemma":0.0002881309,"domain_scores_codex":[0.996888,0.0005838855,0.001077345,0.0003001096,0.0008526583,0.0002980485],"domain_scores_gemma":[0.9966318,0.0002854202,0.001409132,0.0005286256,0.0009422762,0.0002027162],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1626221,0.001586508,0.3491071,0.0002218947,0.01578255,0.0003347658,0.01185017,0.0006127415,0.009162734,0.000008665618,0.000214234,0.4484965],"study_design_scores_gemma":[0.04130117,0.006015606,0.9445041,0.0007260034,0.003398663,0.0002471982,0.0003467731,0.0000613724,0.002809945,0.000004556083,0.0004446469,0.0001399777],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920681,0.00440801,0.00004371105,0.00059169,0.0001696978,0.001784631,0.0002980437,0.000003333361,0.000632847],"genre_scores_gemma":[0.9946283,0.004716341,0.00004519499,0.00004187166,0.0002673659,0.000021309,0.000001437822,0.00005119239,0.0002270523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.595397,"threshold_uncertainty_score":0.6438676,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0284409973456826,"score_gpt":0.3521403557355309,"score_spread":0.3236993583898483,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}